The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121666314 12166631 4 F 20160203 20160712 20160310 20160719 EXP PHEH2016US005750 NOVARTIS 73.19 YR M Y 0.00000 20160719 CN COUNTRY NOT SPECIFIED US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121666314 12166631 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD Y 22334 10 MG TABLET QD
121666314 12166631 2 SS AFINITOR EVEROLIMUS 1 Oral 7.5 MG, QD Y 22334 7.5 MG TABLET QD
121666314 12166631 3 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, UNK Y 22334 5 MG TABLET
121666314 12166631 4 C CLONIDINE. CLONIDINE 1 Oral 0.2 MG, UNK U 0 .2 MG
121666314 12166631 5 C FOSINOPRIL FOSINOPRIL 1 Oral 20 MG, UNK U 0 20 MG
121666314 12166631 6 C LEVOTHYROXINE. LEVOTHYROXINE 1 Oral 75 MG, UNK U 0 75 MG
121666314 12166631 7 C LOVASTATIN. LOVASTATIN 1 Oral 20 MG, UNK U 0 20 MG
121666314 12166631 8 C METOPROLOL. METOPROLOL 1 Oral 100 MG, UNK U 0 100 MG
121666314 12166631 9 C NOVOLOG INSULIN ASPART 1 Subcutaneous 70.30 UNK, UNK U 0
121666314 12166631 10 C ZOFRAN ONDANSETRON HYDROCHLORIDE 1 Oral 8 MG, UNK U 0 8 MG
121666314 12166631 11 C TERAZOSIN TERAZOSINTERAZOSIN HYDROCHLORIDE 1 Oral 2 MG, UNK U 0 2 MG
121666314 12166631 12 C OXYCODONE OXYCODONE 1 Oral 5 MG, UNK U 0 5 MG
121666314 12166631 13 C VITUZ CHLORPHENIRAMINE MALEATEHYDROCODONE BITARTRATE 1 Oral 50000 UNK, UNK U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121666314 12166631 1 Renal cell carcinoma
121666314 12166631 4 Product used for unknown indication
121666314 12166631 5 Product used for unknown indication
121666314 12166631 6 Product used for unknown indication
121666314 12166631 7 Product used for unknown indication
121666314 12166631 8 Product used for unknown indication
121666314 12166631 9 Product used for unknown indication
121666314 12166631 10 Product used for unknown indication
121666314 12166631 11 Product used for unknown indication
121666314 12166631 12 Product used for unknown indication
121666314 12166631 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121666314 12166631 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121666314 12166631 Drug intolerance
121666314 12166631 Fixed drug eruption
121666314 12166631 Infection
121666314 12166631 Malignant neoplasm progression
121666314 12166631 Platelet count decreased
121666314 12166631 Rash
121666314 12166631 Stomatitis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121666314 12166631 1 20160121 20160203 0
121666314 12166631 2 20160204 0
121666314 12166631 3 20160322 0